Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Do TNF inhibitors reduce the risk of myocardial infarction in psoriasis patients?

Armstrong AW.

JAMA. 2013 May 15;309(19):2043-4. doi: 10.1001/jama.2013.4695.

PMID:
23677316
2.

Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis.

Wu JJ, Poon KY, Channual JC, Shen AY.

Arch Dermatol. 2012 Nov;148(11):1244-50. doi: 10.1001/archdermatol.2012.2502. Erratum in: Arch Dermatol. 2013 Feb;149(2):158.

PMID:
22911151
3.
5.
6.

Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.

Ahlehoff O, Skov L, Gislason G, Gniadecki R, Iversen L, Bryld LE, Lasthein S, Lindhardsen J, Kristensen SL, Torp-Pedersen C, Hansen PR.

J Eur Acad Dermatol Venereol. 2015 Jun;29(6):1128-34. doi: 10.1111/jdv.12768.

PMID:
25303139
7.

The effect of systemic psoriasis therapies on the incidence of myocardial infarction: a cohort study.

Abuabara K, Lee H, Kimball AB.

Br J Dermatol. 2011 Nov;165(5):1066-73. doi: 10.1111/j.1365-2133.2011.10525.x.

PMID:
21777216
8.

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.

Solomon DH, Massarotti E, Garg R, Liu J, Canning C, Schneeweiss S.

JAMA. 2011 Jun 22;305(24):2525-31. doi: 10.1001/jama.2011.878.

PMID:
21693740
9.

An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.

van Lümig PP, Menting SP, van den Reek JM, Spuls PI, van Riel PL, van de Kerkhof PC, Fransen J, Kievit W, de Jong EM.

J Eur Acad Dermatol Venereol. 2015 Apr;29(4):752-60. doi: 10.1111/jdv.12675.

PMID:
25229823
10.

Risk of myocardial infarction in psoriasis patients: a retrospective cohort study.

Wu JJ, Choi YM, Bebchuk JD.

J Dermatolog Treat. 2015 Jun;26(3):230-4. doi: 10.3109/09546634.2014.952609.

PMID:
25102892
11.

Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men.

Tseng HF, Slezak JM, Quinn VP, Sy LS, Van den Eeden SK, Jacobsen SJ.

JAMA. 2010 May 5;303(17):1699-706. doi: 10.1001/jama.2010.529.

PMID:
20442385
12.

Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster.

Winthrop KL, Baddley JW, Chen L, Liu L, Grijalva CG, Delzell E, Beukelman T, Patkar NM, Xie F, Saag KG, Herrinton LJ, Solomon DH, Lewis JD, Curtis JR.

JAMA. 2013 Mar 6;309(9):887-95. doi: 10.1001/jama.2013.1099.

13.

Initiation of TNF inhibitor therapy and change in physiologic measures in psoriasis.

Wu JJ, Liu L, Asgari MM, Curtis JR, Harrold L, Salman C, Herrinton LJ.

J Eur Acad Dermatol Venereol. 2014 Oct;28(10):1380-7. doi: 10.1111/jdv.12296.

14.

Risk of myocardial infarction in canadian patients with psoriasis: a retrospective cohort study.

Levesque A, Lachaine J, Bissonnette R.

J Cutan Med Surg. 2013 Nov-Dec;17(6):398-403.

PMID:
24138976
16.

Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.

Accortt NA, Bonafede MM, Collier DH, Iles J, Curtis JR.

Arthritis Rheumatol. 2016 Jan;68(1):67-76. doi: 10.1002/art.39416.

17.

Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.

Grijalva CG, Chen L, Delzell E, Baddley JW, Beukelman T, Winthrop KL, Griffin MR, Herrinton LJ, Liu L, Ouellet-Hellstrom R, Patkar NM, Solomon DH, Lewis JD, Xie F, Saag KG, Curtis JR.

JAMA. 2011 Dec 7;306(21):2331-9. doi: 10.1001/jama.2011.1692.

18.

Combination therapy with tumor necrosis factor inhibitors in psoriasis treatment.

Famenini S, Wu JJ.

Cutis. 2013 Sep;92(3):140-7. Review.

PMID:
24153143
19.

Risk of myocardial infarction in patients with psoriasis.

Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB.

JAMA. 2006 Oct 11;296(14):1735-41.

PMID:
17032986
20.

The Effect of TNF Inhibitors on Cardiovascular Events in Psoriasis and Psoriatic Arthritis: an Updated Meta-Analysis.

Yang ZS, Lin NN, Li L, Li Y.

Clin Rev Allergy Immunol. 2016 Oct;51(2):240-7. doi: 10.1007/s12016-016-8560-9.

PMID:
27300248

Supplemental Content

Support Center